Bank Of New York Mellon Corp Royalty Pharma PLC Transaction History

Bank Of New York Mellon Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $69.4 Million - $78.1 Million	1,772,472 New	1,772,472 $70 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $11 Million - $12.3 Million	275,394 Added 19.84%	1,663,697 $66.8 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $6.93 Million - $8.17 Million	184,671 Added 15.34%	1,388,303 $58.4 Million
Q1 2022 May 11, 2022	SELL	$37.46 - $42.44 $5.37 Million - $6.09 Million	-143,383 Reduced 10.64%	1,203,632 $46.9 Million
Q4 2021 Feb 11, 2022	SELL	$35.17 - $42.48 $12.5 Million - $15.1 Million	-355,974 Reduced 20.9%	1,347,015 $53.7 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $25.6 Million - $30 Million	709,683 Added 71.45%	1,702,989 $61.5 Million
Q2 2021 Aug 11, 2021	BUY	$39.85 - $46.63 $5.56 Million - $6.51 Million	139,591 Added 16.35%	993,306 $40.7 Million
Q1 2021 May 13, 2021	BUY	$42.34 - $52.82 $16.1 Million - $20.1 Million	381,025 Added 80.61%	853,715 $37.2 Million
Q4 2020 Feb 09, 2021	BUY	$36.12 - $50.05 $7.83 Million - $10.9 Million	216,853 Added 84.76%	472,690 $23.7 Million
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $7.89 Million - $9.89 Million	204,551 Added 398.84%	255,837 $10.8 Million
Q2 2020 Aug 12, 2020	BUY	$44.5 - $52.11 $2.28 Million - $2.67 Million	51,286 New	51,286 $2.49 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.